Maziyar Saberi

Maziyar Saberi is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as Chairman of the Scientific Advisory Board and Vice President of Global Innovation at Taconic Biosciences since February 2023, where responsibilities include leading R&D and acquisition strategies. Previously, Maziyar held the position of Chief Scientific Officer at January AI from July 2019 to June 2022, overseeing research, clinical development, and regulatory affairs in personalized digital health. At Applied Molecular Transport, Maziyar led preclinical development and translational biology as Vice President from June 2016 to November 2019. Other roles include Director and Head of Research at Second Genome, Inc., and Associate Director and Head of Pharmacology at NGM Biopharmaceuticals, Inc. Educational background includes study at UC San Diego School of Medicine and the University of Southern California.